Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP

Science Signaling

Volumn 9, Issue 417, 2016, Pages

  Bui, Duyen Amy ^a   Lee, Wendy ^b   White, Anne E ^a   Harper, J Wade ^a   Schackmann, Ron C J ^a   Overholtzer, Michael ^c,d   Selfors, Laura M ^a   Brugge, Joan S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 1; MYOSIN II; MYOSIN LIGHT CHAIN; PROTEIN; PROTEIN KINASE; PROTEIN KINASE HIPPO; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR YAP1; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN; ANILLIN; CDK1 PROTEIN, HUMAN; CONTRACTILE PROTEIN; CYCLIN DEPENDENT KINASE; ECT2 PROTEIN, HUMAN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HIPPO PROTEIN, HUMAN; INADL PROTEIN, HUMAN; MGCRACGAP; ONCOPROTEIN; PHOSPHOPROTEIN; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TIGHT JUNCTION PROTEIN; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

ANEUPLOIDY; ARTICLE; CARCINOGENICITY; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINESIS; CYTOSKELETON; DAUGHTER CELL; GENE EXPRESSION; GENE SILENCING; GENOMIC INSTABILITY; INTERPHASE; MITOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; CELL LINE; CONFOCAL MICROSCOPY; GENETICS; HELA CELL LINE; HUMAN; IMMUNOBLOTTING; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RNA INTERFERENCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE; CONTRACTILE PROTEINS; CYCLIN-DEPENDENT KINASES; CYTOKINESIS; GTPASE-ACTIVATING PROTEINS; HELA CELLS; HUMANS; IMMUNOBLOTTING; MICROSCOPY, CONFOCAL; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIGHT JUNCTION PROTEINS;

EID: 84959547793     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.aaa9227     Document Type: Article

References (81)

1. M. Sudol, Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene 9, 2145-2152 (1994).
2. B. Zhao, X. Ye, J. Yu, L. Li, W. Li, S. Li, J. Yu, J. D. Lin, C.-Y. Wang, A. M. Chinnaiyan, Z.-C. Lai, K.-L. Guan, TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962-1971 (2008).
3. R. Yagi, L.-F. Chen, K. Shigesada, Y. Murakami, Y. Ito, A WW domain-containing Yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J. 18, 2551-2562 (1999).
4. J. Huang, S. Wu, J. Barrera, K. Matthews, D. Pan, The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122, 421-434 (2005).
5. L. Zender, M. S. Spector, W. Xue, P. Flemming, C. Cordon-Cardo, J. Silke, S.-T. Fan, J. M. Luk, M. Wigler, G. J. Hannon, D. Mu, R. Lucito, S. Powers, S. W. Lowe, Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125, 1253-1267 (2006).
6. J. Dong, G. Feldmann, J. Huang, S. Wu, N. Zhang, S. A. Comerford, M. F. Gayyed, R. A. Anders, A. Maitra, D. Pan, Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120-1133 (2007).
7. M. Overholtzer, J. Zhang, G. A. Smolen, B. Muir, W. Li, D. C. Sgroi, C.-X. Deng, J. S. Brugge, D. A. Haber, Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl. Acad. Sci. U.S.A. 103, 12405-12410 (2006).
8. D. Zhou, C. Conrad, F. Xia, J.-S. Park, B. Payer, Y. Yin, G. Y. Lauwers, W. Thasler, J. T. Lee, J. Avruch, N. Bardeesy, Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16, 425-438 (2009).
9. H. Song, K. K. Mak, L. Topol, K. Yun, J. Hu, L. Garrett, Y. Chen, O. Park, J. Chang, R. M. Simpson, C.-Y. Wang, B. Gao, J. Jiang, Y. Yang, Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc. Natl. Acad. Sci. U.S.A. 107, 1431-1436 (2010).
10. N. Zhang, H. Bai, K. K. David, J. Dong, Y. Zheng, J. Cai, M. Giovannini, P. Liu, R. A. Anders, D. Pan, The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev. Cell 19, 27-38 (2010).
11. D. M. Lam-Himlin, J. A. Daniels, M. F. Gayyed, J. Dong, A. Maitra, D. Pan, E. A. Montgomery, R. A. Anders, The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: A novel oncogenic pathway. Int. J. Gastrointest. Cancer 37, 103-109 (2006).
12. C.-L. Da, Y. Xin, J. Zhao, X.-D. Luo, Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions. World J. Gastroenterol. 15, 4055-4061 (2009).
13. A. A. Steinhardt, M. F. Gayyed, A. P. Klein, J. Dong, A. Maitra, D. Pan, E. A. Montgomery, R. A. Anders, Expression of Yes-associated protein in common solid tumors. Hum. Pathol. 39, 1582-1589 (2008).
14. Y. Wang, Q. Dong, Q. Zhang, Z. Li, E. Wang, X. Qiu, Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci. 101, 1279-1285 (2010).
15. M. Z. Xu, T.-J. Yao, N. P. Y. Lee, I. O. L. Ng, Y.-T. Chan, L. Zender, S.W. Lowe, R. T. P. Poon, J. M. Luk, Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115, 4576-4585 (2009).
16. S. Strano, E. Munarriz, M. Rossi, L. Castagnoli, Y. Shaul, A. Sacchi, M. Oren, M. Sudol, G. Cesareni, G. Blandino, Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J. Biol. Chem. 276, 15164-15173 (2001).
17. S. Basu, N. F. Totty, M. S. Irwin, M. Sudol, J. Downward, Akt phosphorylates the Yesassociated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell 11, 11-23 (2003).
18. M. Yuan, V. Tomlinson, R. Lara, D. Holliday, C. Chelala, T. Harada, R. Gangeswaran, C. Manson-Bishop, P. Smith, S. A. Danovi, O. Pardo, T. Crook, C. A. Mein, N. R. Lemoine, L. J. Jones, S. Basu, Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ. 15, 1752-1759 (2008).
19. N. Yabuta, N. Okada, A. Ito, T. Hosomi, S. Nishihara, Y. Sasayama, A. Fujimori, D. Okuzaki, H. Zhao, M. Ikawa, M. Okabe, H. Nojima, Lats2 is an essential mitotic regulator required for the coordination of cell division. J. Biol. Chem. 282, 19259-19271 (2007).
20. X. Yang, K. Yu, Y. Hao, D.-m. Li, R. Stewart, K. L. Insogna, T. Xu, LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1. Nat. Cell Biol. 6, 609-617 (2004).
21. N. Yabuta, S. Mukai, A. Okamoto, D. Okuzaki, H. Suzuki, K. Torigata, K. Yoshida, N. Okada, D. Miura, A. Ito, M. Ikawa, M. Okabe, H. Nojima, N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability. J. Cell Sci. 126, 508-520 (2013).
22. J. P. McPherson, L. Tamblyn, A. Elia, E. Migon, A. Shehabeldin, E. Matysiak-Zablocki, B. Lemmers, L. Salmena, A. Hakem, J. Fish, F. Kassam, J. Squire, B. G. Bruneau, M. P. Hande, R. Hakem, Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J. 23, 3677-3688 (2004).
23. J. Bothos, R. L. Tuttle, M. Ottey, F. C. Luca, T. D. Halazonetis, Human LATS1 is a mitotic exit network kinase. Cancer Res. 65, 6568-6575 (2005).
24. S. Tommasi, R. Dammann, Z. Zhang, Y. Wang, L. Liu, W. M. Tsark, S. P. Wilczynski, J. Li, M. You, G. P. Pfeifer, Tumor susceptibility of Rassf1a knockout mice. Cancer Res. 65, 92-98 (2005).
25. C. Guo, S. Tommasi, L. Liu, J.-K. Yee, R. Dammann, G. P. Pfeifer, RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr. Biol. 17, 700-705 (2007).
26. M. Bettencourt-Dias, R. Giet, R. Sinka, A. Mazumdar, W. G. Lock, F. Balloux, P. J. Zafiropoulos, S. Yamaguchi, S. Winter, R. W. Carthew, M. Cooper, D. Jones, L. Frenz, D. M. Glover, Genome-wide survey of protein kinases required for cell cycle progression. Nature 432, 980-987 (2004).
27. G. Normand, R. W. King, Understanding cytokinesis failure. Adv. Exp. Med. Biol. 676, 27-55 (2010).
28. W. M. Bement, A. L. Miller, G. Von Dassow, Rho GTPase activity zones and transient contractile arrays. Bioessays 28, 983-993 (2006).
29. K. Hayashi, S. Yonemura, T. Matsui, S. Tsukita, Immunofluorescence detection of ezrin/radixin/moesin (ERM) proteins with their carboxyl-terminal threonine phosphorylated in cultured cells and tissues. J. Cell Sci. 112 (Pt. 8), 1149-1158 (1999).
30. S. Yonemura, K. Hirao-Minakuchi, Y. Nishimura, Rho localization in cells and tissues. Exp. Cell Res. 295, 300-314 (2004).
31. G. T. Charras, C.-K. Hu, M. Coughlin, T. J. Mitchison, Reassembly of contractile actin cortex in cell blebs. J. Cell Biol. 175, 477-490 (2006).
32. A. J. Piekny, M. Glotzer, Anillin is a scaffold protein that links RhoA, actin, and myosin during cytokinesis. Curr. Biol. 18, 30-36 (2008).
33. J. P. Moorman, D. A. Bobak, C. S. Hahn, Inactivation of the small GTP binding protein Rho induces multinucleate cell formation and apoptosis in murine T lymphoma EL4. J. Immunol. 156, 4146-4153 (1996).
34. K. Tsubakimoto, K. Matsumoto, H. Abe, J. Ishii, M. Amano, K. Kaibuchi, T. Endo, Small GTPase RhoD suppresses cell migration and cytokinesis. Oncogene 18, 2431-2440 (1999).
35. C. B. O'Connell, S. P. Wheatley, S. Ahmed, Y.-l. Wang, The small GTP-binding protein rho regulates cortical activities in cultured cells during division. J. Cell Biol. 144, 305-313 (1999).
36. M. Aepfelbacher, M. Essler, K. Luber De Quintana, P. C. Weber, ADP-ribosylation of the GTP-binding protein RhoA blocks cytoplasmic division in human myelomonocytic cells. Biochem. J. 308 (Pt. 3), 853-858 (1995).
37. N. Dephoure, C. Zhou, J. Villén, S. A. Beausoleil, C. E. Bakalarski, S. J. Elledge, S. P. Gygi, A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 105, 10762-10767 (2008).
38. F. Niiya, X. Xie, K. S. Lee, H. Inoue, T. Miki, Inhibition of cyclin-dependent kinase 1 induces cytokinesis without chromosome segregation in an ECT2 and MgcRacGAPdependent manner. J. Biol. Chem. 280, 36502-36509 (2005).
39. S. Yang, L. Zhang, M. Liu, R. Chong, S.-J. Ding, Y. Chen, J. Dong, CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation. Cancer Res. 73, 6722-6733 (2013).
40. M. E. Sowa, E. J. Bennett, S. P. Gygi, J. W. Harper, Defining the human deubiquitinating enzyme interaction landscape. Cell 138, 389-403 (2009).
41. C. Behrends, M. E. Sowa, S. P. Gygi, J. W. Harper, Network organization of the human autophagy system. Nature 466, 68-76 (2010).
42. A. L. Couzens, J. D. R. Knight, M. J. Kean, G. Teo, A. Weiss, W. H. Dunham, Z.-Y. Lin, R. D. Bagshaw, F. Sicheri, T. Pawson, J. L. Wrana, H. Choi, A.-C. Gingras, Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinasephosphatase interactions. Sci. Signal. 6, rs15 (2013).
43. J. Zhang, G. A. Smolen, D. A. Haber, Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer Res. 68, 2789-2794 (2008).
44. A. M. Vigneron, R. L. Ludwig, K. H. Vousden, Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP. Genes Dev. 24, 2430-2439 (2010).
45. Y. Hao, A. Chun, K. Cheung, B. Rashidi, X. Yang, Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J. Biol. Chem. 283, 5496-5509 (2008).
46. D. Matallanas, D. Romano, K. Yee, K. Meissl, L. Kucerova, D. Piazzolla, M. Baccarini, J. K. Vass, W. Kolch, E. O'Neill, RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol. Cell 27, 962-975 (2007).
47. T. Oka, V. Mazack, M. Sudol, Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J. Biol. Chem. 283, 27534-27546 (2008).
48. F.-X. Yu, B. Zhao, N. Panupinthu, J. L. Jewell, I. Lian, L. H. Wang, J. Zhao, H. Yuan, K. Tumaneng, H. Li, X.-D. Fu, G. B. Mills, K.-L. Guan, Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780-791 (2012).
49. W. Wang, J. Huang, X. Wang, J. Yuan, X. Li, L. Feng, J.-I. Park, J. Chen, PTPN14 is required for the density-dependent control of YAP1. Genes Dev. 26, 1959-1971 (2012).
50. M. Paramasivam, A. Sarkeshik, J. R. Yates III, M. J. G. Fernandes, D. McCollum, Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol. Biol. Cell 22, 3725-3733 (2011).
51. S. Hauri, A. Wepf, A. Van Drogen, M. Varjosalo, N. Tapon, R. Aebersold, M. Gstaiger, Interaction proteome of human Hippo signaling: Modular control of the co-activator YAP1. Mol. Syst. Biol. 9, 713 (2013).
52. J.-S. Lee, K. Kamijo, N. Ohara, T. Kitamura, T. Miki, MgcRacGAP regulates cortical activity through RhoA during cytokinesis. Exp. Cell. Res. 293, 275-282 (2004).
53. J. R. Boyne, H. M. Yosuf, P. Bieganowski, C. Brenner, C. Price, Yeast myosin light chain, Mlc1p, interacts with both IQGAP and class II myosin to effect cytokinesis. J. Cell Sci. 113 (Pt. 24), 4533-4543 (2000).
54. D. J. Fishkind, L.-g. Cao, Y.-l. Wang, Microinjection of the catalytic fragment of myosin light chain kinase into dividing cells: Effects on mitosis and cytokinesis. J. Cell Biol. 114, 967-975 (1991).
55. C. Lindon, J. Pines, Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells. J. Cell Biol. 164, 233-241 (2004).
56. J. Birkenfeld, P. Nalbant, B. P. Bohl, O. Pertz, K. M. Hahn, G. M. Bokoch, GEF-H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases. Dev. Cell 12, 699-712 (2007).
57. M. Mikawa, L. Su, S. J. Parsons, Opposing roles of p190RhoGAP and Ect2 RhoGEF in regulating cytokinesis. Cell Cycle 7, 2003-2012 (2008).
58. M. P. Somma, B. Fasulo, G. Cenci, E. Cundari, M. Gatti, Molecular dissection of cytokinesis by RNA interference in Drosophila cultured cells. Mol. Biol. Cell 13, 2448-2460 (2002).
59. A. Echard, G. R. X. Hickson, E. Foley, P. H. O'Farrell, Terminal cytokinesis events uncovered after an RNAi screen. Curr. Biol. 14, 1685-1693 (2004).
60. A. Huttenlocher, R. R. Sandborg, A. F. Horwitz, Adhesion in cell migration. Curr. Opin. Cell Biol. 7, 697-706 (1995).
61. M. Raftopoulou, A. Hall, Cell migration: Rho GTPases lead the way. Dev. Biol. 265, 23-32 (2004).
62. Y. Kawano, Y. Fukata, N. Oshiro, M. Amano, T. Nakamura, M. Ito, F. Matsumura, M. Inagaki, K. Kaibuchi, Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J. Cell Biol. 147, 1023-1038 (1999).
63. M. Sullivan, D. O. Morgan, Finishing mitosis, one step at a time. Nat. Rev. Mol. Cell Biol. 8, 894-903 (2007).
64. K. Shin, S. Straight, B. Margolis, PATJ regulates tight junction formation and polarity in mammalian epithelial cells. J. Cell Biol. 168, 705-711 (2005).
65. K. Shin, Q. Wang, B. Margolis, PATJ regulates directional migration of mammalian epithelial cells. EMBO Rep. 8, 158-164 (2007).
66. M. A. Schlüter, C. S. Pfarr, J. Pieczynski, E. L. Whiteman, T.W. Hurd, S. Fan, C.-J. Liu, B. Margolis, Trafficking of Crumbs3 during cytokinesis is crucial for lumen formation. Mol. Biol. Cell 20, 4652-4663 (2009).
67. L. Y. Chan, A. Amon, Spindle position is coordinated with cell-cycle progression through establishment of mitotic exit-activating and -inhibitory zones. Mol. Cell 39, 444-454 (2010).
68. S. Chiba, M. Ikeda, K. Katsunuma, K. Ohashi, K. Mizuno, MST2-and Furry-mediated activation of NDR1 kinase is critical for precise alignment of mitotic chromosomes. Curr. Biol. 19, 675-681 (2009).
69. T. Chiyoda, N. Sugiyama, T. Shimizu, H. Naoe, Y. Kobayashi, J. Ishizawa, Y. Arima, H. Tsuda, M. Ito, K. Kaibuchi, D. Aoki, Y. Ishihama, H. Saya, S. Kuninaka, LATS1/WARTS phosphorylates MYPT1 to counteract PLK1 and regulate mammalian mitotic progression. J. Cell Biol. 197, 625-641 (2012).
70. E. Bertini, T. Oka, M. Sudol, S. Strano, G. Blandino, YAP: At the crossroad between transformation and tumor suppression. Cell Cycle 8, 49-57 (2009).
71. E. R. Barry, T. Morikawa, B. L. Butler, K. Shrestha, R. De la Rosa, K. S. Yan, C. S. Fuchs, S. T. Magness, R. Smits, S. Ogino, C. J. Kuo, F. D. Camargo, Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493, 106-110 (2013).
72. T. Boveri, Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J. Cell Sci. 121 (Suppl. 1), 1-84 (2008).
73. T. Fujiwara, M. Bandi, M. Nitta, E. V. Ivanova, R. T. Bronson, D. Pellman, Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437, 1043-1047 (2005).
74. C. M. Caldwell, R. A. Green, K. B. Kaplan, APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice. J. Cell Biol. 178, 1109-1120 (2007).
75. T. W. Corson, B. L. Gallie, KIF14 mRNA expression is a predictor of grade and outcome in breast cancer. Int. J. Cancer 119, 1088-1094 (2006).
76. G. Roversi, R. Pfundt, R. F. Moroni, I. Magnani, S. Van Reijmersdal, B. Pollo, H. Straatman, L. Larizza, E. F. P. M. Schoenmakers, Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines. Oncogene 25, 1571-1583 (2006).
77. T. I. Zack, S. E. Schumacher, S. L. Carter, A. D. Cherniack, G. Saksena, B. Tabak, M. S. Lawrence, C.-Z. Zhang, J. Wala, C. H. Mermel, C. Sougnez, S. B. Gabriel, B. Hernandez, H. Shen, P. W. Laird, G. Getz, M. Meyerson, R. Beroukhim, Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 45, 1134-1140 (2013).
78. N. J. Ganem, Z. Storchova, D. Pellman, Tetraploidy, aneuploidy and cancer. Curr. Opin. Genet. Dev. 17, 157-162 (2007).
79. J.-M. Schvartzman, R. Sotillo, R. Benezra, Mitotic chromosomal instability and cancer: Mouse modelling of the human disease. Nat. Rev. Cancer 10, 102-115 (2010).
80. J. Debnath, S. K. Muthuswamy, J. S. Brugge, Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256-268 (2003).
81. S. A. Beausoleil, J. Villén, S. A. Gerber, J. Rush, S. P. Gygi, A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat. Biotechnol. 24, 1285-1292 (2006).